Accelerating Drug Translation: Role of Coronary Computed Tomography Angiography Plaque Imaging Candidates as Surrogate Biomarkers

  • 0National Heart Research Institute Singapore, National Heart Centre Singapore, Singapore; CVS.AI, National Heart Research Institute of Singapore, Singapore; Duke-NUS Medical School, National University of Singapore, Singapore; Department of Cardiology National Heart Centre Singapore, Singapore.

|

|

Summary

This summary is machine-generated.

Coronary artery disease (CAD) drug development needs better biomarkers. Coronary computed tomography angiography (CTA) shows promise for evaluating atherosclerosis plaque, potentially improving clinical trials.

Area Of Science

  • Cardiovascular imaging and drug development
  • Atherosclerosis research
  • Biomarker discovery

Background

  • Current coronary artery disease (CAD) drug development faces challenges with clinical outcomes, requiring large trials.
  • A validated surrogate biomarker reflecting atherosclerosis progression is needed.
  • Emerging therapies target inflammation and lipid pathways, necessitating new evaluation methods.

Purpose Of The Study

  • To review coronary computed tomography angiography (CTA) measures for evaluating CAD drug targets.
  • To assess CTA's potential role in the drug development pipeline.
  • To highlight the need for stakeholder collaboration in validating CTA endpoints.

Main Methods

  • Review of morphological and quantitative plaque components using coronary CTA.
  • Assessment of pathophysiological correlation with other atherosclerosis imaging.
  • Evaluation of association with major adverse cardiovascular events and drug responsiveness.

Main Results

  • Coronary CTA can image, characterize, and quantify specific plaque components.
  • Morphological and quantitative CTA measures show potential as surrogate endpoints.
  • Advancements in CTA technology necessitate standardization and validation.

Conclusions

  • Coronary CTA offers a promising imaging modality for CAD drug development.
  • Validated CTA endpoints could accelerate therapeutic innovation and trial efficiency.
  • Collaboration among stakeholders is crucial for advancing CTA in clinical trials.

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT 01:25

119

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...

Imaging Studies for Cardiovascular System V: CT 01:28

66

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...

Acute Coronary Syndrome III: Diagnostic Studies 01:30

23

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...

Coronary Artery Disease V: Interprofessional Care 01:27

33

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...

Coronary Artery Disease I: Introduction 01:30

57

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...

Imaging Studies for Cardiovascular System III: X-Ray 01:20

298

The most common cardiovascular diagnostic test is an X-ray. It produces images of the heart, blood vessels, and adjacent structures.
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...